Abstract
Endocrine therapy is the most elegant form of treatment for breast cancer as it uses the body’s own mechanisms to fight the cancer and is less invasive or toxic than other methods. The ‘mechanisms’ behind this treatment give an insight into the nature of breast cancer, and so may lead to better understanding of the causes of the disease and thus the possibility of preventing it.
Keywords
Breast Cancer Body Image Aromatase Inhibitor Menopausal Symptom Medroxyprogesterone Acetate
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- Beatson, G.T. (1896) On the management of inoperable cases of carcinoma of the mamma: suggestion for new method of treatment with illustrative cases. Lancet, 2, 104–7, 162–5.CrossRefGoogle Scholar
- Casey, A. (1981) Oestrogen receptor and breast cancer. Nursing Times, 16 April.Google Scholar
- Cavalli, F. (1989) Endocrine Therapy of Breast Cancer III, Springer-Verlag, Berlin.CrossRefGoogle Scholar
- Crichlow, R.W. and Evans, D.B. (1987) Cancer in the Male Breast, in Breast Cancer: Diagnosis and Treatment (ed. I. Ariel and J. Cleary), McGraw-Hill, New York.Google Scholar
- Dunne, C.F. (1988) Hormonal therapy for breast cancer. Cancer Nursing 11(5), 288–94.PubMedCrossRefGoogle Scholar
- Early Breast Cancer Trialist’s Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. The Lancet, 339(8784), 1–15.Google Scholar
- Feldman, J.E. (1989) Ovarian failure and cancer treatment: incidence and interventions for the premenopausal woman. Oncology Nursing Forum, 16(5), 651–7.PubMedGoogle Scholar
- Furr, B.J.A. and Milsted, R.A.V. (1988) LH-RH Analogues in Cancer Treatment in Endocrine Management of Cancer: Volume 2 Contemporary Therapy (ed. B. Stoll), Karger, Basle.Google Scholar
- Goodman, M. (1988) Concepts of hormonal manipulation in the treatment of cancer. Oncology Nursing Forum, 15(5), 639–47.PubMedGoogle Scholar
- Howie, C. (1987) Sparing the flushes. Nursing Times, 83(49), 51–3.Google Scholar
- Huggins, C. and Bergenstal, D.M. (1952) Inhibition of human mammary and prostatic cancer by adrenalectomy. Cancer Research, 12, 134–41.PubMedGoogle Scholar
- Jordan, V.C. (1986) Estrogen/Antiestrogen Action and Breast Cancer Therapy, Wisconsin Press, Madison.Google Scholar
- Jordan, V.C. and Morrow, M. (1994) Should clinicians be concerned about the carcinogenic potential of tamoxifen? European Journal of Cancer, 30A(11), 1714–21.CrossRefGoogle Scholar
- Levine-Silverman, S. (1989) The menopausal hot flash: a procrustean bed of research. Journal of Advanced Nursing, 14, 939–49.PubMedCrossRefGoogle Scholar
- Osborne, C.K. (1985) Heterogeneity in hormone receptor status in primary and metastatic breast cancer. Seminars in Oncology, 12(1), supplement 1, 12–16.Google Scholar
- Padmanabhan, N., Howell, A. and Rubens, R.D. (1986) Mechanism of action of adjuvant chemotherapy in early breast cancer. The Lancet, ii, 411–14.CrossRefGoogle Scholar
- Powles, T.J. (1983) The role of aromatase inhibitors in breast cancer. Seminars in Oncology, 10, supplement 4, 4.Google Scholar
- Sque, M. (1985) What’s in a name? Nursing Mirror, 160(8), 22.Google Scholar
- Stewart, HJ. (1992) Scottish Cancer Trials Breast Group — The Scottish trial of adjuvant tamoxifen in node negative breast cancer. Monogr. National CancerInstitute, 11, 117–20.Google Scholar
- Vallis, K. and Waxman, J. (1988) Tumour Flare in Hormonal Therapy, in Endocrine Management of Cancer; Volume 2 Contemporary Therapy (ed. B. Stoll), Karger, Basle.Google Scholar
- Voda, A. (1986) Menopause. Annual Review of Nursing Research, 4, 55–75.PubMedGoogle Scholar
- Webb, C. (1985) Sexuality, Nursing and Health, J. Wiley and Sons, Chichester.Google Scholar
Copyright information
© Springer Science+Business Media Dordrecht 1996